Drugs / lipoprostaglandin E1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02338440 | Jan 2015 → Dec 2019 | vascular occlusion disorder | Seoul National University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lipoprostaglandin E1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02338440 ↗ |
| Route | Other | “continuous infusion” NCT02338440 ↗ |